Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)

NCT01015404 is registered in ClinicalTrials.gov with Kaken Pharmaceutical as lead sponsor.

NCT NCT01015404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01015404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)
Lead sponsor
Kaken Pharmaceutical
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2009
Completion date
Not reported
Enrollment
25 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

periodontitis